Sen. Bernie Sanders’ health committee grilled a panel of PBM and pharmaceutical executives Wednesday in preparation for a vote on PBM legislation, expected Thursday
As state and federal governments grapple with reining in prescription drug prices, one company’s approach shows how difficult this may be
Apr 13, 2023
Image
U.S. Senator Bernie Sanders of Vermont speaking at a town meeting at the Phoenix Convention Center in Phoenix, Arizona, on July 18, 2015.
|
GAGE SKIDMORE/CC BY-SA 2.0
CVS Health, UnitedHealthcare and Cigna’s pharmacy benefit managers have aggressively played the insulin makers off one another, fattening their own accounts
Mar 9, 2023
Image
Elizabeth Fisher Smith sits with husband Matt and dogs Caspian and Gretl at the table where she spends hours every day preparing IV hydration and nutrition, on which she depends to survive.
|
ARTHUR ALLEN/KHN
Home and outpatient infusions are a growing business in the United States, but the less profitable parts of the business — as well as the vulnerable patients they serve — are at serious risk.
Immunizations against the respiratory syncytial virus are nearing the market, but a glitch in congressional language may make it difficult to allow children from low-income families to get it.
Pfizer is sinking billions in profits from COVID-19 into developing and marketing potential new treatment blockbusters for conditions like migraines, sickle cell disease and obesity.